Skip to main content
OpenTrials
Completed

NCT Number: NCT00950898

The Acute Effects of Coffee on Glucose Metabolism

The purpose of this study was to determine the acute effects of decaffeinated coffee, caffeinated coffee and caffeine on glucose metabolism in humans

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Brooklyn College of the City University of New York

Brooklyn, New York, 11210, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy young males
  • nonsmokers
  • moderate alcohol users

Exclusion criteria

  • not on any medications that could alter glucose metabolism
  • no history of blood disorders

Treatment and study plan

decaff

Other

2 mugs of decaffeinated coffee

caffcoff

Other

2 mugs of caffeinated coffee

Caffeine

Other

2 mugs of hot water containing caffeine

Placebo

Other

2 mugs of hot water

Primary outcomes

  1. plasma glucose levels

    Time frame: 0, 10, 30, 60, 90, and 120 minutes.

Secondary outcomes

  1. plasma insulin

    Time frame: 0, 10, 30, 60, 90, and 120 minutes

Sponsors and collaborators

Lead sponsor

Brooklyn College of the City University of New York

Other

Registry information

Official study title

Human Trial of the Acute Effects of Coffee on Glucose Metabolism

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
Aug 3, 2009
Registry last updated
Aug 3, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.